Report Description

India carbidopa market is expected to grow at a formidable rate during the forecast period. The India carbidopa market is driven by increase in growth in aging population. Additionally, initiatives taken by the government of the country in terms of providing funds for research and development is further expected to boost the demand through FY2026. Continuous demand of carbidopa to treat Parkinson’s disease is further predicted to increase the product demand in the forthcoming years, thereby bolstering the market growth.

The India carbidopa market is segmented based on composition, rate of drug delivery, dose, source, form, distribution channel, application, end user, company, and region. Based on rate of drug delivery, the market is segmented into immediate v/s sustained release. Among them, the sustained drug release segment is anticipated to grow at a high CAGR in the market over the next 5 years which is attributable to maximum utilization of the drug coupled with increased safety margin of potent drug. In addition to this, sustained release of drug into body tends to improve patient compliance on account of less frequent drug administration which is further boosting the segmental growth in the years to come.

The major players operating in the India carbidopa market are Wockhardt Ltd., Dr. Reddy’s Laboratories Ltd., Intas Pharmaceuticals Ltd., Cadila Pharmaceuticals Ltd., Sun Pharmaceutical Industries Limited, Teva Pharmaceuticals Industries Ltd., Atom Pharma Pvt. Ltd., Taj Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., GlaxoSmithKline Pharmaceuticals Ltd. and others. Major companies are developing advanced technologies, receiving approvals from regulatory bodies, and launching new products in order to stay competitive in the market. Other inorganic growth strategies include mergers & acquisitions, joint ventures, new technologies platforms and new product developments in order to sustain themselves amidst fierce competition.

Years considered for this report:

Historical Years: FY2016-FY2019

Base Year: FY2020

Estimated Year: FY2021

Forecast Period: FY2022–FY2026

Objective of the Study:

  • To analyze and estimate the market size of India carbidopa market from FY2016 to FY2019.
  • To estimate and forecast the market size of India carbidopa market from FY2020 to FY2026 and growth rate until FY2026.
  • To classify and forecast India carbidopa market based on composition, rate of drug delivery, dose, source, form, distribution channel, application, end user, company, and regional distribution.
  • To identify dominant region or segment in the India carbidopa market.
  • To identify drivers and challenges for India carbidopa market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in India carbidopa market.
  • To identify and analyze the profile of leading players operating in India carbidopa market.
  • To identify key sustainable strategies adopted by market players in India carbidopa market.

Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of India carbidopa market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Carbidopa manufacturers/ suppliers/ distributors
  • Market research and consulting firms
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to carbidopa

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, India carbidopa market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • India Carbidopa Market, By Composition:
    • Single
    • Combinational
  • India Carbidopa Market, By Rate of Drug Delivery:
    • Immediate
    • Sustained Release
  • India Carbidopa Market, By Dose:
    • 10 mg
    • 25mg
    • 50 mg
    • 100 mg
    • 250 mg
    • Others
  • India Carbidopa Market, By Source:
    • In-house
    • Contract Manufacturing Organizations
  • India Carbidopa Market, By Form:
    • Tablet
    • Capsule
    • Suspension
    • Others
  • India Carbidopa Market, By Distribution Channel:
    • Online
    • Offline
  • India Carbidopa Market, By Application:
    • Idiopathic Parkinson's Disease
    • Postencephalitic Parkinsonism
    • Symptomatic Parkinsonism
    • Others
  • India Carbidopa Market, By End User:
    • Adult
    • Pediatric
  • India Carbidopa Market, By Region:
    • North
    • South
    • East
    • West

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in India carbidopa market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
India Carbidopa market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]  

Table of content

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Carbidopa Market

4.    Executive Summary

5.    Manufacturing Carbidopa

5.1.  Raw Material

5.2.  Machinery

5.3.  Manufacturing Methods

5.4.  Contact Details of Machinery & Raw Material Suppliers

6.    Pharmacodynamic Overview of Carbidopa

6.1.  Mechanism of Action

6.2.  Absorption

6.3.  Volume of Distribution

6.4.  Protein Binding

6.5.  Metabolism

6.6.  Route of Elimination

6.7.  Half-Life

6.8.  Clearance

6.9.  Toxicity

7.    India Carbidopa Market Outlook

7.1.  Market Size & Forecast

7.1.1.     By Value & Volume

7.2.  Market Share & Forecast

7.2.1.     By Composition (Single, Combinational)

7.2.2.     By Rate of Drug Delivery (Immediate v/s Sustained Release)

7.2.3.     By Dose (10 mg, 25mg, 50 mg, 100 mg, 250 mg, Others)

7.2.4.     By Source (In-house v/s Contract Manufacturing Organizations)

7.2.5.     By Form (Tablet, Capsule, Suspension, Others)

7.2.6.     By Distribution Channel (Online v/s Offline)

7.2.7.     By Application (Idiopathic Parkinson's Disease (Paralysis Agitans), Postencephalitic Parkinsonism, Symptomatic Parkinsonism Including (Shakiness, Stiffness, Difficulty Moving, Spasms, Poor Muscle Control, Tremors) and Others)

7.2.8.     By End User (Adult v/s Pediatric)

7.2.9.     By Region (North, East, South, West)

7.2.10.  By Company

7.3.  Product Market Map

8.    Market Dynamics

8.1.  Drivers/Opportunities

8.2.  Challenges/Restraints

9.    Market Trends & Developments

10.  Policy & Regulatory Landscape

10.1.              Custom Duty & Taxes

10.2.              Government Subsidy & Benefits

10.3.              Relevant Policies & Regulations (GMP, USFDA, WHO Certifications)

11.  Import & Export Analysis

12.  Pricing Analysis

13.  India Economic Profile

14.  Competitive Landscape

14.1.              Company Profiles

14.1.1.  Wockhardt Ltd.      Company Brief      Production Plants & Capacity (If Available)      Financials (If Available)      Captive Consumption Vs Merchant Sale      Current & Future Plans

14.1.2.  Dr. Reddy’s Laboratories Ltd.

14.1.3.  Intas Pharmaceuticals Ltd.

14.1.4.  Cadila Pharmaceuticals Ltd.

14.1.5.  Sun Pharmaceutical Industries Limited

14.1.6.  Teva Pharmaceuticals Industries Ltd.

14.1.7.  Atom Pharma Pvt. Ltd.

14.1.8.  Taj Pharmaceuticals Ltd.

14.1.9.  Alembic Pharmaceuticals Ltd.

14.1.10.                GlaxoSmithKline Pharmaceuticals Ltd.

15.  Strategic Recommendations

16. About Us & Disclaimer 

Figures and Tables

Frequently asked questions






Sakshi Bajaal

Business Consultant
Press Release

India Carbidopa Market to grow at a formidable rate During the Forecast Period

Nov, 2020

Increase in the prevalence of Parkinson’s disease is expected to drive the growth of India carbidopa market during the forecast period.